Bio-Rad Laborator…
USUSDBio-Rad Laboratories Inc (US:BIO-B) — Biotechnology: Laboratory Analytical Instruments. Количество бирж, на которых торгуются акции компании: 2. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О компании
- Сайт
- bio-rad.com
- Сектор
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Штаб-квартира
- HERCULES, United States
- Генеральный директор
- Norman D. Schwartz
- Сотрудники
- 8 300
- Основана
- 1952
- Акций в обращении
- 21.7 млн
- Свободное обращение
- 21.35 млн
- Рыночная капитализация
- 10.16 млрд USD
- Инсайдеры
- 16.41%
- Институциональные инвесторы
- 91.26%
- Отрасль (SIC)
- Laboratory Analytical Instruments
- LEI
- 549300ZC1GPV35XYDK53
- FCF
- 353 млн USD
- Долг
- 1.20 млрд USD1.9 г. FCF
- Прибыль и FCF — за 12 месяцев до 30.06.2026 года (последний отчет компании).
Описание
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Новости этой недели
Новостей с сайта компании пока нет.
Крупнейшие держатели
| Держатель | Доля | Акции | Дата отчета |
|---|---|---|---|
| SCHWARTZ NORMAN D (Chief… | ≈14.6% | 3.16 млн | 2026-09-04 |
| First Eagle Investment M… | 12.02% | 2.61 млн | 2026-06-30 |
| First Eagle Funds-First… | 8.67% | 1.88 млн | 2026-07-31 |
| Blackrock Inc. | 7.84% | 1.7 млн | 2026-06-30 |
| Dimensional Fund Advisor… | 4.36% | 944 548 | 2026-06-30 |
| SmallCap World Fund Inc | 4.07% | 881 719 | 2026-06-30 |
| Vanguard Capital Managem… | 3.81% | 826 972 | 2026-06-30 |
| Ariel Investments, LLC | 3.77% | 816 751 | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.77% | 816 198 | 2026-06-30 |
| iShares Trust-iShares Co… | 2.91% | 630 798 | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 2.7% | 584 782 | 2026-06-30 |
| Earnest Partners LLC | 2.68% | 580 752 | 2026-06-30 |
| State Street Corporation | 2.64% | 571 762 | 2026-06-30 |
| Bank of America Corporat… | 2.26% | 490 412 | 2026-06-30 |
| Capital World Investors | 2.13% | 462 457 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.95% | 423 193 | 2026-06-30 |
| Ariel Investment Trust-A… | 1.61% | 349 270 | 2026-06-30 |
| DFA INVESTMENT DIMENSION… | 1.34% | 291 328 | 2026-07-31 |
| MFS Series Trust IV-MFS… | 1.28% | 276 995 | 2026-05-31 |
| VANGUARD INDEX FUNDS-Van… | 1.24% | 267 971 | 2026-06-30 |
| FPA FUNDS TRUST-FPA Cres… | 1.13% | 244 376 | 2026-06-30 |
| COREY COLLEEN (Officer) | ≈0.09% | 19 550 | 2025-09-05 |
| CROWLEY MICHAEL W (Offic… | ≈0.04% | 8 171 | 2025-03-14 |
| LAKKARAJU ROOP KALYAN (C… | ≈0.02% | 4 150 | 2026-09-04 |
| EVRAN SEDAT (Officer) | ≈0.02% | 3 603 | 2026-09-04 |
| BARRY JAMES (Officer) | ≈0.01% | 2 024 | 2026-09-04 |
| DIVINCENZO JONATHAN P (P… | ≈0.01% | 1 963 | 2026-09-04 |
| ENGELHARDT EVA ANETTE (O… | ≈0.01% | 1 828 | 2026-09-04 |
| ALLISON SCHWARTZ (Direct… | ≈0.01% | 1 734 | 2026-09-04 |
| ENLOE COURTNEY C (Genera… | ≈0.01% | 1 651 | 2026-09-04 |
